MIB1 and neoplasm: Previous CMTs studies associated higher MIB-1 LI with other aggressive tumour features (larger size [5,13], infiltrative growth [6], high histological grade [13]), higher risk of metastatic disease [11] and decreased DFS and OS [7,9], strengthening our findings.